Inulin as a Clinical Therapeutic Intervention in Metabolic Associated Fatty Liver Disease

References

• Wilson, B.; Whelan, K. Prebiotic Inulin-Type Fructans and Galacto-Oligosaccharides: Definition, Specificity, Function, and Application in Gastrointestinal Disorders. J. Gastroenterol. Hepatol. 2017, 32(Suppl 1), 64–68. DOI: 10.1111/jgh.13700.
   PubMedGoogle Scholar
• Reis, S. A.; Dos Conceição, L. L.; Rosa, D. D.; Dos S. Dias, M. M.; Peluzio, M. D. C. G. Mechanisms Used by Inulin-Type Fructans to Improve the Lipid Profile. Nutr. Hosp. 2014, 31(2), 528–534. DOI: 10.3305/nh.2015.31.2.7706.
   PubMed Web of Science ®Google Scholar
• Delzenne, N. M.; Cani, P. D.; Neyrinck, A. M. Modulation of Glucagon-like Peptide 1 and Energy Metabolism by Inulin and Oligofructose: Experimental Data. J. Nutr. 2007, 137(11 Suppl), 2547S–2551S. DOI: 10.1093/jn/137.11.2547S.
   PubMed Web of Science ®Google Scholar
• Roberfroid, M. B.;. Introducing Inulin-Type Fructans. Br. J. Nutr. 2005, 93(S1), S13–S25. DOI: 10.1079/BJN20041350.
   PubMed Web of Science ®Google Scholar
• Kolida, S.; Gibson, G. R. Prebiotic Capacity of Inulin-Type Fructans. J. Nutr. 2007, 137(11 Suppl), 2503S–2506S. DOI: 10.1093/jn/137.11.2503S.
   PubMed Web of Science ®Google Scholar
• van Loo, J.; Coussement, P.; de Leenheer, L.; Hoebregs, H.; Smits, G. On the Presence of Inulin and Oligofructose as Natural Ingredients in the Western Diet. Crit. Rev. Food Sci. Nutr. 1995, 35(6), 525–552. DOI: 10.1080/10408399509527714.
   PubMed Web of Science ®Google Scholar
• Tsurumaki, M.; Kotake, M.; Iwasaki, M.; Saito, M.; Tanaka, K.; Aw, W.; Fukuda, S.; Tomita, M.; The Application of Omics Technologies in the Functional Evaluation of Inulin and Inulin-Containing Prebiotics Dietary Supplementation. Nutr. Diabetes. 2015, 511, e185. DOI:10.1038/nutd.2015.35.
   PubMed Web of Science ®Google Scholar
• Martinez, R. C. R.; Bedani, R.; Saad, S. M. I. Scientific Evidence for Health Effects Attributed to the Consumption of Probiotics and Prebiotics: An Update for Current Perspectives and Future Challenges. Br. J. Nutr. 2015, 114(12), 1993–2015. DOI: 10.1017/S0007114515003864.
   PubMed Web of Science ®Google Scholar
• Alles, M. S.; Hautvast, J. G. A. J.; Nagengast, F. M.; Hartemink, R.; Van Laere, K. M. J.; Jansen, J. B. M. J. Fate of Fructo-Oligosaccharides in the Human Intestine. Br. J. Nutr. 1996, 76(2), 211–221. DOI: 10.1079/BJN19960026.
   PubMed Web of Science ®Google Scholar
• Roberfroid, M.; Gibson, G. R.; Hoyles, L.; McCartney, A. L.; Rastall, R.; Rowland, I.; Wolvers, D.; Watzl, B.; Szajewska, H.; Stahl, B.; et al. Prebiotic Effects: Metabolic and Health Benefits. Br. J. Nutr. 2010, 104(Suppl (S2)), S1–63. DOI: 10.1017/S0007114510003363.
   PubMedGoogle Scholar
• Levrat, M. A.; Favier, M. L.; Moundras, C.; Rémésy, C.; Demigné, C.; Morand, C. Role of Dietary Propionic Acid and Bile Acid Excretion in the Hypocholesterolemic Effects of Oligosaccharides in Rats. J. Nutr. 1994, 124(4), 531–538. DOI: 10.1093/jn/124.4.531.
   PubMed Web of Science ®Google Scholar
• Weitkunat, K.; Schumann, S.; Petzke, K. J.; Blaut, M.; Loh, G.; Klaus, S. Effects of Dietary Inulin on Bacterial Growth, Short-Chain Fatty Acid Production and Hepatic Lipid Metabolism in Gnotobiotic Mice. J. Nutr. Biochem. 2015, 26(9), 929–937. DOI: 10.1016/j.jnutbio.2015.03.010.
   PubMed Web of Science ®Google Scholar
• Commane, D. M.; Shortt, C. T.; Silvi, S.; Cresci, A.; Hughes, R. M.; Rowland, I. R. Effects of Fermentation Products of Pro- and Prebiotics on Trans-Epithelial Electrical Resistance in an in Vitro Model of the Colon. Nutr. Cancer. 2005, 51(1), 102–109. DOI: 10.1207/s15327914nc5101_14.
   PubMed Web of Science ®Google Scholar
• Cani, P. D.; Osto, M.; Geurts, L.; Everard, A. Involvement of Gut Microbiota in the Development of Low-Grade Inflammation and Type 2 Diabetes Associated with Obesity. Gut Microbes. 2012, 3(4), 279–288. DOI: 10.4161/gmic.19625.
   PubMed Web of Science ®Google Scholar
• Catry, E.; Bindels, L. B.; Tailleux, A.; Lestavel, S.; Neyrinck, A. M.; Goossens, J.-F.; Lobysheva, I.; Plovier, H.; Essaghir, A.; Demoulin, J.-B.;.; et al. Targeting the Gut Microbiota with Inulin-Type Fructans: Preclinical Demonstration of a Novel Approach in the Management of Endothelial Dysfunction. Gut.2018, 67(2), 271–283. DOI: 10.1136/gutjnl-2016-313316.
   PubMed Web of Science ®Google Scholar
• Kolida, S.; Tuohy, K.; Gibson, G. R. Prebiotic Effects of Inulin and Oligofructose. Br. J. Nutr. 2002, 87 Suppl 2(6), S193–7. DOI: 10.1079/BJNBJN/2002537.
   PubMedGoogle Scholar
• Ducros, V.; Arnaud, J.; Tahiri, M.; Coudray, C.; Bornet, F.; Bouteloup-Demange, C.; Brouns, F.; Rayssiguier, Y.; Roussel, A. M. Influence of Short-Chain Fructo-Oligosaccharides (Sc-fos) on Absorption of Cu, Zn, and Se in Healthy Postmenopausal Women. J. Am. Coll. Nutr. 2005, 24(1), 30–37. DOI: 10.1080/07315724.2005.10719440.
   PubMed Web of Science ®Google Scholar
• Tahiri, M.; Tressol, J. C.; Arnaud, J.; Bornet, F.; Bouteloup-Demange, C.; Feillet-Coudray, C.; Ducros, V.; Pépin, D.; Brouns, F.; Rayssiguier, A. M.; et al. Five-Week Intake of Short-Chain Fructo-Oligosaccharides Increases Intestinal Absorption and Status of Magnesium in Postmenopausal Women. J. Bone Miner. Res. 2001, 16(11), 2152–2160. DOI: 10.1359/jbmr.2001.16.11.2152.
   PubMed Web of Science ®Google Scholar
• Weaver, C. M.;. Inulin, Oligofructose and Bone Health: Experimental Approaches and Mechanisms. Br. J. Nutr. 2005, 93(S1), S99–S103. DOI: 10.1079/BJN20041358.
   PubMedGoogle Scholar
• Coudray, C.; Bellanger, J.; Castiglia-Delavaud, C.; Rémésy, C.; Vermorel, M.; Rayssignuier, Y. Effect of Soluble or Partly Soluble Dietary Fibres Supplementation on Absorption and Balance of Calcium, Magnesium, Iron and Zinc in Healthy Young Men. Eur. J. Clin. Nutr. 1997, 51(6), 375–380. DOI: 10.1038/sj.ejcn.1600417.
   PubMed Web of Science ®Google Scholar
• Greger, J. L.;. Nondigestible Carbohydrates and Mineral Bioavailability. J. Nutr. 1999, 129(7), 1434S–1435S. DOI: 10.1093/jn/129.7.1434S.
   PubMed Web of Science ®Google Scholar
• Qin, J.; Li, R.; Raes, J.; Arumugam, M.; Burgdorf, K. S.; Manichanh, C.; Nielsen, T.; Pons, N.; Levenez, F.; Yamada, T.;.; et al. A Human Gut Microbial Gene Catalogue Established by Metagenomic Sequencing. Nature.2010, 464(7285), 59–65. DOI: 10.1038/nature08821.
   PubMed Web of Science ®Google Scholar
• Roberfroid, M. B.;. Inulin-Type Fructans: Functional Food Ingredients. J. Nutr. 2007, 137(11 Suppl), 2493S–2502S. DOI: 10.1093/jn/137.11.2493S.
   PubMed Web of Science ®Google Scholar
• Loh, G.; Eberhard, M.; Brunner, R. M.; Hennig, U.; Kuhla, S.; Kleessen, B.; Metges, C. C. Inulin Alters the Intestinal Microbiota and Short-Chain Fatty Acid Concentrations in Growing Pigs Regardless of Their Basal Diet. J. Nutr. 2006, 136(5), 1198–1202. DOI: 10.1093/jn/136.5.1198.
   PubMed Web of Science ®Google Scholar
• Sghir, A.; Chow, J. M.; Mackie, R. I. Continuous Culture Selection of Bifidobacteria and Lactobacilli from Human Faecal Samples Using Fructooligosaccharide as Selective Substrate. J. Appl. Microbiol. 1998, 85(4), 769–777. DOI: 10.1111/j.1365-2672.1998.00590.x.
   PubMed Web of Science ®Google Scholar
• Gibson, G. R.; Beatty, E. R.; Wang, X.; Cummings, J. H. Selective Stimulation of Bifidobacteria in the Human Colon by Oligofructose and Inulin. Gastroenterology. 1995, 108(4), 975–982. DOI: 10.1016/0016-5085(95)90192-2.
   PubMed Web of Science ®Google Scholar
• Ramirez-Farias, C.; Slezak, K.; Fuller, Z.; Duncan, A.; Holtrop, G.; Louis, P. Effect of Inulin on the Human Gut Microbiota: Stimulation of Bifidobacterium Adolescentis and Faecalibacterium Prausnitzii. Br. J. Nutr. 2009, 101(4), 541–550. DOI: 10.1017/S0007114508019880.
   PubMed Web of Science ®Google Scholar
• Jenkins, D. J.; Kendall, C. W.; Vuksan, V. Inulin, Oligofructose and Intestinal Function. J. Nutr. 1999, 129(7 Suppl)), 1431S–3S. DOI: 10.1093/jn/129.7.1431S.
   PubMed Web of Science ®Google Scholar
• Rycroft, C. E.; Jones, M. R.; Gibson, G. R.; Rastall, R. A. A. Comparative in Vitro Evaluation of the Fermentation Properties of Prebiotic Oligosaccharides. J. Appl. Microbiol. 2001, 91(5), 878–887. DOI: 10.1046/j.1365-2672.2001.01446.x.
   PubMed Web of Science ®Google Scholar
• Morel, F. B.; Dai, Q.; Ni, J.; Thomas, D.; Parnet, P.; Fança-Berthon, P. α-Galacto-Oligosaccharides Dose-Dependently Reduce Appetite and Decrease Inflammation in Overweight Adults. J. Nutr. 2015, 145(9), 2052–2059. DOI: 10.3945/jn.114.204909.
   PubMed Web of Science ®Google Scholar
• Roberfroid, M. B.; Van Loo, J. A.; Gibson, G. R. The Bifidogenic Nature of Chicory Inulin and Its Hydrolysis Products. J. Nutr. 1998, 128(1), 11–19. DOI: 10.1093/jn/128.1.11.
   PubMed Web of Science ®Google Scholar
• Guarner, F.;. Inulin and Oligofructose: Impact on Intestinal Diseases and Disorders. Br. J. Nutr. 2005, 93(S1), S61–S65. DOI: 10.1079/BJN20041345.
   PubMedGoogle Scholar
• Sevane, N.; Bialade, F.; Velasco, S.; Rebolé, A.; Rodríguez, M. L.; Ortiz, L. T.; Cañón, J.; Dunner, S.; Te Pas, M. F. Dietary Inulin Supplementation Modifies Significantly the Liver Transcriptomic Profile of Broiler Chickens. PLoS One. 2014, 9, 6. DOI: 10.1371/journal.pone.0098942.
   Web of Science ®Google Scholar
• Claesson, M. J.; Cusack, S.; O’Sullivan, O.; Greene-Diniz, R.; de Weerd, H.; Flannery, E.; Marchesi, J. R.; Falush, D.; Dinan, T.; Fitzgerald, G.; et al. Composition, Variability, and Temporal Stability of the Intestinal Microbiota of the Elderly. Proc. Natl. Acad. Sci. U. S. A. 2011, 108(Suppl (Supplement_1)), 4586–4591. DOI: 10.1073/pnas.1000097107.
   PubMedGoogle Scholar
• Lesniewska, V.; Rowland, I.; Cani, P. D.; Neyrinck, A. M.; Delzenne, N. M.; Naughton, P. J. Effect on Components of the Intestinal Microflora and Plasma Neuropeptide Levels of Feeding Lactobacillus Delbrueckii, Bifidobacterium Lactis, and Inulin to Adult and Elderly Rats. Appl. Environ. Microbiol. 2006, 72(10), 6533–6538. DOI: 10.1128/AEM.00915-06.
   PubMed Web of Science ®Google Scholar
• Eslam, M.; Newsome, P. N.; Sarin, S. K.; Anstee, Q. M.; Targher, G.; Romero-Gomez, M.; Zelber-Sagi, S.; Wai-Sun Wong, V.; Dufour, J. F.; Schattenberg, J. M.;.; et al. A New Definition for Metabolic Dysfunction-Associated Fatty Liver Disease: An International Expert Consensus Statement. J. Hepatol. Elsevier B.V. July 1, 2020. 202–209. 10.1016/j.jhep.2020.03.039. 73,
   PubMed Web of Science ®Google Scholar
• Murag, S.; Ahmed, A.; Kim, D. Recent Epidemiology of Nonalcoholic Fatty Liver Disease. Gut Liver. 2020. DOI: 10.5009/gnl20127.
   PubMed Web of Science ®Google Scholar
• Petta, S.; Gastaldelli, A.; Rebelos, E.; Bugianesi, E.; Messa, P.; Miele, L.; Svegliati-Baroni, G.; Valenti, L.; Bonino, F.; Pathophysiology of Non Alcoholic Fatty Liver Disease. Int. J. Mol. Sci. MDPI AG. December 11 2016, 17, 2082. DOI: 10.3390/ijms17122082.
   PubMed Web of Science ®Google Scholar
• Trautwein, E. A.; Rieckhoff, D.; Erbersdobler, H. F. Dietary Inulin Lowers Plasma Cholesterol and Triacylglycerol and Alters Biliary Bile Acid Profile in Hamsters. J. Nutr. 1998, 128(11), 1937–1943. DOI: 10.1093/jn/128.11.1937.
   PubMed Web of Science ®Google Scholar
• Demigné, C.; Morand, C.; Levrat, M.-A.; Besson, C.; Moundras, C.; Rémésy, C. Effect of Propionate on Fatty Acid and Cholesterol Synthesis and on Acetate Metabolism in Isolated Rat Hepatocytes. Br. J. Nutr. 1995, 74(2), 209–219. DOI: 10.1079/BJN19950124.
   PubMed Web of Science ®Google Scholar
• Everard, A.; Lazarevic, V.; Derrien, M.; Girard, M.; Muccioli, G. G.; Muccioli, G. M.; Neyrinck, A. M.; Possemiers, S.; Van Holle, A.; François, P.;.; et al. Responses of Gut Microbiota and Glucose and Lipid Metabolism to Prebiotics in Genetic Obese and Diet-Induced Leptin-Resistant Mice. Diabetes.2011, 60(11), 2775–2786. DOI: 10.2337/db11-0227.
   PubMed Web of Science ®Google Scholar
• Dewulf, E. M.; Cani, P. D.; Claus, S. P.; Fuentes, S.; Puylaert, P. G. B.; Neyrinck, A. M.; Bindels, L. B.; de Vos, W. M.; Gibson, G. R.; Thissen, J.-P.;.; et al. Insight into the Prebiotic Concept: Lessons from an Exploratory, Double Blind Intervention Study with Inulin-Type Fructans in Obese Women. Gut.2013, 62(8), 1112–1121. DOI: 10.1136/gutjnl-2012-303304.
   PubMed Web of Science ®Google Scholar
• Salazar, N.; Dewulf, E. M.; Neyrinck, A. M.; Bindels, L. B.; Cani, P. D.; Mahillon, J.; de Vos, W. M.; Thissen, J.-P.; Gueimonde, M.; de Los Reyes-gavilán, C. G.;.; et al. Inulin-Type Fructans Modulate Intestinal Bifidobacterium Species Populations and Decrease Fecal Short-Chain Fatty Acids in Obese Women. Clin. Nutr. 2015, 34(3), 501–507. DOI: 10.1016/j.clnu.2014.06.001.
   PubMed Web of Science ®Google Scholar
• Guess, N. D.; Dornhorst, A.; Oliver, N.; Bell, J. D.; Thomas, E. L.; Frost, G. S.; Randomized Controlled, A. Trial: The Effect of Inulin on Weight Management and Ectopic Fat in Subjects with Prediabetes. Nutr. Metab. 2015, 12(1), 36. DOI: 10.1186/s12986-015-0033-2.
   Google Scholar
• Daubioul, C.; Rousseau, N.; Demeure, R.; Gallez, B.; Taper, H.; Declerck, B.; Delzenne, N. Dietary Fructans, but Not Cellulose, Decrease Triglyceride Accumulation in the Liver of Obese Zucker Fa/Fa Rats. J. Nutr. 2002, 132(5), 967–973. DOI: 10.1093/jn/132.5.967.
   PubMed Web of Science ®Google Scholar
• Rault-Nania, M.-H.; Gueux, E.; Demougeot, C.; Demigné, C.; Rock, E.; Mazur, A. Inulin Attenuates Atherosclerosis in Apolipoprotein E-Deficient Mice. Br. J. Nutr. 2006, 96(5), 840–844. DOI: 10.1017/BJN20061913.
   PubMed Web of Science ®Google Scholar
• Balcázar-Muñoz, B. R.; Martínez-Abundis, E.; González-Ortiz, M.; [Effect of Oral Inulin Administration on Lipid Profile and Insulin Sensitivity in Subjects with Obesity and Dyslipidemia]. Rev. Med. Chil. 2003, 131(6), 597–604.
   PubMed Web of Science ®Google Scholar
• de Luis, D. A.; de la Fuente, B.; Izaola, O.; Conde, R.; Gutiérrez, S.; Morillo, M.; Teba Torres, C.; [Randomized Clinical Trial with a Inulin Enriched Cookie on Risk Cardiovascular Factor in Obese Patients]. Nutr. Hosp. 2010, 25(1), 53–59.
   PubMed Web of Science ®Google Scholar
• Letexier, D.; Diraison, F.; Beylot, M. Addition of Inulin to a Moderately High-Carbohydrate Diet Reduces Hepatic Lipogenesis and Plasma Triacylglycerol Concentrations in Humans. Am. J. Clin. Nutr. 2003, 77(3), 559–564. DOI: 10.1093/ajcn/77.3.559.
   PubMed Web of Science ®Google Scholar
• Bourdon, I.; Yokoyama, W.; Davis, P.; Hudson, C.; Backus, R.; Richter, D.; Knuckles, B.; Schneeman, B. O. Postprandial Lipid, Glucose, Insulin, and Cholecystokinin Responses in Men Fed Barley Pasta Enriched with β-Glucan. Am. J. Clin. Nutr. 1999, 69(1), 55–63. DOI: 10.1093/ajcn/69.1.55.
   PubMed Web of Science ®Google Scholar
• Ooi, L. G.; Ahmad, R.; Yuen, K. H.; Liong, M. T. Lactobacillus Acidophilus CHO-220 and Inulin Reduced Plasma Total Cholesterol and Low-Density Lipoprotein Cholesterol via Alteration of Lipid Transporters. J. Dairy Sci. 2010, 93(11), 5048–5058. DOI: 10.3168/jds.2010-3311.
   PubMed Web of Science ®Google Scholar
• Cani, P. D.; Dewever, C.; Delzenne, N. M. Inulin-Type Fructans Modulate Gastrointestinal Peptides Involved in Appetite Regulation (Glucagon-like Peptide-1 and Ghrelin) in Rats. Br. J. Nutr. 2004, 92(3), 521–526. DOI: 10.1079/BJN20041225.
   PubMed Web of Science ®Google Scholar
• Quiñones, M.; Fernø, J.; Al-Massadi, O.; Ghrelin and Liver Disease. Rev. Endocr. Metabol. Disord. Springer March 1 2020, 45–56. 10.1007/s11154-019-09528-6. 21,
   PubMed Web of Science ®Google Scholar
• Ezquerro, S.; Mocha, F.; Frühbeck, G.; Guzmán-Ruiz, R.; Valentí, V.; Mugueta, C.; Becerril, S.; Catalán, V.; Gómez-Ambrosi, J.; Silva, C.;.; et al. Ghrelin Reduces TNF-α-Induced Human Hepatocyte Apoptosis, Autophagy, and Pyroptosis: Role in Obesity-Associated NAFLD. J. Clin. Endocrinol. Metab. 2020, 104(1), 21–37. DOI: 10.1210/jc.2018-01171.
   Web of Science ®Google Scholar
• Bernsmeier, C.; Meyer-Gerspach, A. C.; Blaser, L. S.; Jeker, L.; Steinert, R. E.; Heim, M. H.; Beglinger, C.; Petta, S. Glucose-Induced Glucagon-like Peptide 1 Secretion Is Deficient in Patients with Non-Alcoholic Fatty Liver Disease. PLoS One. 2014, 9(1), e87488. DOI: 10.1371/journal.pone.0087488.
   PubMed Web of Science ®Google Scholar
• Bifari, F.; Manfrini, R.; Dei Cas, M.; Berra, C.; Siano, M.; Zuin, M.; Paroni, R.; Folli, F.; Multiple Target Tissue Effects of GLP-1 Analogues on Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH). Pharmacol. Res. Academic Press. November 1 2018, 137, 219–229. DOI: 10.1016/j.phrs.2018.09.025.
   PubMed Web of Science ®Google Scholar
• Wu, W.-T.; Chen, H.-L. Konjac Glucomannan and Inulin Systematically Modulate Antioxidant Defense in Rats Fed a High-Fat Fiber-Free Diet. J. Agric. Food Chem. 2011, 59(17), 9194–9200. DOI: 10.1021/jf202060p.
   PubMed Web of Science ®Google Scholar
• Ortigaõ, R.; Pimentel-Nunes, P.; Dinis-Ribeiro, M.; Libânio, D.; Gastrointestinal Microbiome-What We Need to Know in Clinical Practice. GE Portuguese J. Gastroenterol. S. Karger AG 2019. . DOI: 10.1159/000505036.
   Google Scholar
• Kelly, G.;. Inulin-Type Prebiotics: A Review. (Part 2). Altern. Med. Rev. 2009, 14(1), 36–55.
   PubMedGoogle Scholar
• Abrams, S. A.; Griffin, I. J.; Hawthorne, K. M.; Ellis, K. J. Effect of Prebiotic Supplementation and Calcium Intake on Body Mass Index. J. Pediatr. 2007, 151(3), 293–298. DOI: 10.1016/j.jpeds.2007.03.043.
   PubMed Web of Science ®Google Scholar
• Daubioul, C. A.; Taper, H. S.; De Wispelaere, L. D.; Delzenne, N. M. Dietary Oligofructose Lessens Hepatic Steatosis, but Does Not Prevent Hypertriglyceridemia in Obese Zucker Rats. J. Nutr. 2000, 130(5), 1314–1319. DOI: 10.1093/jn/130.5.1314.
   PubMed Web of Science ®Google Scholar
• Archer, B. J.; Johnson, S. K.; Devereux, H. M.; Baxter, A. L. Effect of Fat Replacement by Inulin or Lupin-Kernel Fibre on Sausage Patty Acceptability, Post-Meal Perceptions of Satiety and Food Intake in Men. Br. J. Nutr. 2004, 91(4), 591–599. DOI: 10.1079/BJN20031088.
   PubMed Web of Science ®Google Scholar
• Cani, P. D.; Joly, E.; Horsmans, Y.; Delzenne, N. M. Oligofructose Promotes Satiety in Healthy Human: A Pilot Study. Eur. J. Clin. Nutr. 2006, 60(5), 567–572. DOI: 10.1038/sj.ejcn.1602350.
   PubMed Web of Science ®Google Scholar
• Pitocco, D.; Tesauro, M.; Alessandro, R.; Ghirlanda, G.; Cardillo, C. Oxidative Stress in Diabetes: Implications for Vascular and Other Complications. Int. J. Mol. Sci. 2013, 14(11), 21525–21550. DOI: 10.3390/ijms141121525.
   PubMed Web of Science ®Google Scholar
• Krentz, A. J.; Lipoprotein Abnormalities and Their Consequences for Patients with Type 2 Diabetes. Diabetes. Obes. Metab. 2003, 5(Suppl 1), S19–27. DOI: 10.1046/j.1462-8902.2003.0310.x.
   PubMed Web of Science ®Google Scholar
• Bahmani, F.; Tajadadi-Ebrahimi, M.; Kolahdooz, F.; Mazouchi, M.; Hadaegh, H.; Jamal, A.-S.; Mazroii, N.; Asemi, S.; Asemi, Z. The Consumption of Synbiotic Bread Containing Lactobacillus Sporogenes and Inulin Affects Nitric Oxide and Malondialdehyde in Patients with Type 2 Diabetes Mellitus: Randomized, Double-Blind, Placebo-Controlled Trial. J. Am. Coll. Nutr. 2016, 35(6), 506–513. DOI: 10.1080/07315724.2015.1032443.
   PubMed Web of Science ®Google Scholar
• Farhangi, M. A.; Javid, A. Z.; Dehghan, P.; The Effect of Enriched Chicory Inulin on Liver Enzymes, Calcium Homeostasis and Hematological Parameters in Patients with Type 2 Diabetes Mellitus: A Randomized Placebo-Controlled Trial. Prim. Care Diabetes 2016, 10(4), 265–271. DOI:10.1016/j.pcd.2015.10.009.
   PubMed Web of Science ®Google Scholar
• Delzenne, N. M.; Knudsen, C.; Beaumont, M.; Rodriguez, J.; Neyrinck, A. M.; Bindels, L. B. Contribution of the Gut Microbiota to the Regulation of Host Metabolism and Energy Balance: A Focus on the Gut-Liver Axis. Proc. Nutr. Soc. 2019, 78(3), 319–328. DOI: 10.1017/S0029665118002756.
   PubMed Web of Science ®Google Scholar
• Beylot, M.;. Effects of Inulin-Type Fructans on Lipid Metabolism in Man and in Animal Models. Br. J. Nutr. 2005, 93(S1), S163–S168. DOI: 10.1079/BJN20041339.
   PubMedGoogle Scholar
• Agheli, N.; Kabir, M.; Berni-Canani, S.; Petitjean, E.; Boussairi, A.; Luo, J.; Bornet, F.; Slama, G.; Rizkalla, S. W. Plasma Lipids and Fatty Acid Synthase Activity are Regulated by Short-Chain Fructo-Oligosaccharides in Sucrose-Fed Insulin-Resistant Rats. J. Nutr. 1998, 128(8), 1283–1288. DOI: 10.1093/jn/128.8.1283.
   PubMed Web of Science ®Google Scholar
• Fiordaliso, M.; Kok, N.; Desager, J. P.; Goethals, F.; Deboyser, D.; Roberfroid, M.; Delzenne, N. Dietary Oligofructose Lowers Triglycerides, Phospholipids and Cholesterol in Serum and Very Low Density Lipoproteins of Rats. Lipids. 1995, 30(2), 163–167. DOI: 10.1007/BF02538270.
   PubMed Web of Science ®Google Scholar
• Loguercio, C.; Federico, A.; Tuccillo, C.; Terracciano, F.; D’Auria, M. V.; De Simone, C.; Del Vecchio Blanco, C. Beneficial Effects of a Probiotic VSL#3 on Parameters of Liver Dysfunction in Chronic Liver Diseases. J. Clin. Gastroenterol. 2005, 39(6), 540–543. DOI: 10.1097/01.mcg.0000165671.25272.0f.
   PubMed Web of Science ®Google Scholar
• Velayudham, A.; Dolganiuc, A.; Ellis, M.; Petrasek, J.; Kodys, K.; Mandrekar, P.; Szabo, G. VSL#3 Probiotic Treatment Attenuates Fibrosis without Changes in Steatohepatitis in a Diet-Induced Nonalcoholic Steatohepatitis Model in Mice. Hepatology. 2009, 49(3), 989–997. DOI: 10.1002/hep.22711.
   PubMed Web of Science ®Google Scholar
• Barbero-Becerra, V.; Nuño-Lámbarri, N.; Álvarez-Arce, A.; Juárez-Hernández, E.; Uribe, M.; Pérez-Monter, C. Effect of Inulin on the Microbiota and the Regulation of Inflammation in a Non-Alcoholic Fatty Liver Disease Model. In Nutrtition Science & Practice Conference; American Society of Parenteral and Enteral Nutrition: Phoenix, AZ, 2019; pp 61–62.
   Google Scholar
• Diraison, F.; Moulin, P.; Beylot, M.; Contribution of Hepatic De Novo Lipogenesis and Reesterification of Plasma Non Esterified Fatty Acids to Plasma Triglyceride Synthesis during Non-Alcoholic Fatty Liver Disease. Diabetes Metab. 2003, 29(5), 478–485. DOI: 10.1016/S1262-3636(07)70061-7.
   PubMed Web of Science ®Google Scholar
• Thuy, S.; Ladurner, R.; Volynets, V.; Wagner, S.; Strahl, S.; Königsrainer, A.; Maier, K.-P.; Bischoff, S. C.; Bergheim, I. Nonalcoholic Fatty Liver Disease in Humans Is Associated with Increased Plasma Endotoxin and Plasminogen Activator Inhibitor 1 Concentrations and with Fructose Intake. J. Nutr. 2008, 138(8), 1452–1455. DOI: 10.1093/jn/138.8.1452.
   PubMed Web of Science ®Google Scholar
• Daubioul, C. A.; Horsmans, Y.; Lambert, P.; Danse, E.; Delzenne, N. M. Effects of Oligofructose on Glucose and Lipid Metabolism in Patients with Nonalcoholic Steatohepatitis: Results of a Pilot Study. Eur. J. Clin. Nutr. 2005, 59(5), 723–726. DOI: 10.1038/sj.ejcn.1602127.
   PubMed Web of Science ®Google Scholar
• Wigg, A. J.; Roberts-Thomson, I. C.; Dymock, R. B.; McCarthy, P. J.; Grose, R. H.; Cummins, A. G. The Role of Small Intestinal Bacterial Overgrowth, Intestinal Permeability, Endotoxaemia, and Tumour Necrosis Factor Alpha in the Pathogenesis of Non-Alcoholic Steatohepatitis. Gut. 2001, 48(2), 206–211. DOI: 10.1136/gut.48.2.206.
   PubMed Web of Science ®Google Scholar
• Malaguarnera, M.; Vacante, M.; Antic, T.; Giordano, M.; Chisari, G.; Acquaviva, R.; Mastrojeni, S.; Malaguarnera, G.; Mistretta, A.; Li Volti, G.;.; et al. Bifidobacterium Longum with Fructo-Oligosaccharides in Patients with Non Alcoholic Steatohepatitis. Dig. Dis. Sci. 2012, 57(2), 545–553. DOI: 10.1007/s10620-011-1887-4.
   PubMed Web of Science ®Google Scholar
• Chambers, E. S.; Byrne, C. S.; Rugyendo, A.; Morrison, D. J.; Preston, T.; Tedford, C.; Bell, J. D.; Thomas, L.; Akbar, A. N.; Riddell, N. E.;.; et al. 2019. The Effects of Dietary Supplementation with Inulin and Inulin-Propionate Ester on Hepatic Steatosis in Adults with Non-Alcoholic Fatty Liver Disease. Diabetes. Obes. Metab. 21(2), 372–376, DOI: 10.1111/dom.13500.
   PubMed Web of Science ®Google Scholar
• Ferolla, S. M.; Couto, C. A.; Costa-Silva, L.; Armiliato, G. N. A.; Pereira, C. A. S.; Martins, F. S.; Ferrari, M. D. L. A.; Vilela, E. G.; Torres, H. O. G.; Cunha, A. S.; et al. Beneficial Effect of Synbiotic Supplementation on Hepatic Steatosis and Anthropometric Parameters, but Not on Gut Permeability in a Population with Nonalcoholic Steatohepatitis. Nutrients.2016, 8(7), 397. DOI: 10.3390/nu8070397.
   PubMed Web of Science ®Google Scholar
• Javadi, L.; Khoshbaten, M.; Safaiyan, A.; Ghavami, M.; Abbasi, M. M.; Gargari, B. P.; Pro- and Prebiotic Effects on Oxidative Stress and Inflammatory Markers in Non-Alcoholic Fatty Liver Disease. Asia Pac. J. Clin. Nutr. 2018, 27(5), 1031–1039. DOI: 10.6133/apjcn.042018.05.
   PubMed Web of Science ®Google Scholar
• Kruse, H.-P.; Kleessen, B.; Blaut, M. Effects of Inulin on Faecal Bifidobacteria in Human Subjects. Br. J. Nutr. 1999, 82(5), 375–382. DOI: 10.1017/S0007114599001622.
   PubMed Web of Science ®Google Scholar
• Asgharian, A.; Askari, G.; Esmailzade, A.; Feizi, A.; Mohammadi, V. The Effect of Symbiotic Supplementation on Liver Enzymes, C-Reactive Protein and Ultrasound Findings in Patients with Non-Alcoholic Fatty Liver Disease: A Clinical Trial. Int. J. Prev. Med. 2016, 7(1), 59. DOI: 10.4103/2008-7802.178533.
   PubMedGoogle Scholar
• Bakhshimoghaddam, F.; Shateri, K.; Sina, M.; Hashemian, M.; Alizadeh, M. Daily Consumption of Synbiotic Yogurt Decreases Liver Steatosis in Patients with Nonalcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial. J. Nutr. 2018, 148(8), 1276–1284. DOI: 10.1093/jn/nxy088.
   PubMed Web of Science ®Google Scholar
• Eslamparast, T.; Poustchi, H.; Zamani, F.; Sharafkhah, M.; Malekzadeh, R.; Hekmatdoost, A. Synbiotic Supplementation in Nonalcoholic Fatty Liver Disease: A Randomized, Double-Blind, Placebo-Controlled Pilot Study. Am. J. Clin. Nutr. 2014, 99(3), 535–542. DOI: 10.3945/ajcn.113.068890.
   PubMed Web of Science ®Google Scholar
• Mofidi, F.; Poustchi, H.; Yari, Z.; Nourinayyer, B.; Merat, S.; Sharafkhah, M.; Malekzadeh, R.; Hekmatdoost, A. Synbiotic Supplementation in Lean Patients with Non-Alcoholic Fatty Liver Disease: A Pilot, Randomised, Double-Blind, Placebo-Controlled, Clinical Trial. Br. J. Nutr. 2017, 117(5), 662–668. DOI: 10.1017/S0007114517000204.
   PubMed Web of Science ®Google Scholar
• Sayari, S.; Neishaboori, H.; Jameshorani, M.; Combined Effects of Synbiotic and Sitagliptin versus Sitagliptin Alone in Patients with Nonalcoholic Fatty Liver Disease. Clin. Mol. Hepatol. 2018, 243, 331–338. DOI:10.3350/cmh.2018.0006.
   PubMed Web of Science ®Google Scholar
• Scorletti, E.; Afolabi, P. R.; Miles, E. A.; Smith, D. E.; Almehmadi, A.; Alshathry, A.; Moyses, H. E.; Clough, G. F.; Wright, M.; Patel, J.; et al. Design and Rationale of the INSYTE Study: A Randomised, Placebo Controlled Study to Test the Efficacy of A Synbiotic on Liver Fat, Disease Biomarkers and Intestinal Microbiota in Non-Alcoholic Fatty Liver Disease. Contemp. Clin. Trials. 2018, 71, 113–123. doi:10.1016/j.cct.2018.05.010.
   PubMed Web of Science ®Google Scholar
• Gibson, G. R.; Scott, K. P.; Rastall, R. A.; Tuohy, K. M.; Hotchkiss, A.; Dubert-Ferrandon, A.; Gareau, M.; Murphy, E. F.; Saulnier, D.; Loh, G.; et al. 2010. Dietary Prebiotics: Current Status and New Definition. Food Sci. Technol. Bull. Funct. Foods. 7(1), 1–19, DOI: 10.1616/1476-2137.15880.
   Google Scholar
• Buddington, R. K.; Williams, C. H.; Chen, S. C.; Witherly, S. A. Dietary Supplement of Neosugar Alters the Fecal Flora and Decreases Activities of Some Reductive Enzymes in Human Subjects. Am. J. Clin. Nutr. 1996, 63(5), 709–716. DOI: 10.1093/ajcn/63.5.709.
   PubMed Web of Science ®Google Scholar
• Tuohy, K. M.; Kolida, S.; Lustenberger, A. M.; Gibson, G. R. The Prebiotic Effects of Biscuits Containing Partially Hydrolysed Guar Gum and Fructo-Oligosaccharides – A Human Volunteer Study. Br. J. Nutr. 2001, 86(3), 341–348. DOI: 10.1079/bjn2001394.
   PubMed Web of Science ®Google Scholar
• Williams, C. H.; Witherly, S. A.; Buddington, R. K. Influence of Dietary Neosugar on Selected Bacterial Groups of the Human Faecal Microbiota. Microb. Ecol. Health Dis. 1994, 7(2), 91–97. DOI: 10.3109/08910609409141577.
   Web of Science ®Google Scholar
• Kleessen, B.; Sykura, B.; Zunft, H. J.; Blaut, M. Effects of Inulin and Lactose on Fecal Microflora, Microbial Activity, and Bowel Habit in Elderly Constipated Persons. Am. J. Clin. Nutr. 1997, 65(5), 1397–1402. DOI: 10.1093/ajcn/65.5.1397.
   PubMed Web of Science ®Google Scholar
• Stone-Dorshow, T.; Levitt, M. D. Gaseous Response to Ingestion of a Poorly Absorbed Fructo-Oligosaccharide Sweetener. Am. J. Clin. Nutr. 1987, 46(1), 61–65. DOI: 10.1093/ajcn/46.1.61.
   PubMed Web of Science ®Google Scholar
• Rumessen, J. J.; Gudmand-Høyer, E. Fructans of Chicory: Intestinal Transport and Fermentation of Different Chain Lengths and Relation to Fructose and Sorbitol Malabsorption. Am. J. Clin. Nutr. 1998, 68(2), 357–364. DOI: 10.1093/ajcn/68.2.357.
   PubMed Web of Science ®Google Scholar
• Blaut, M.;. Relationship of Prebiotics and Food to Intestinal Microflora. Eur. J. Nutr. 2002, 41 Suppl 1, I11–6. DOI: 10.1007/s00394-002-1102-7.
   PubMedGoogle Scholar
• de Luis, D. A.; de la Fuente, B.; Izaola, O.; Aller, R.; Gutiérrez, S.; Morillo, M.; Double Blind Randomized Clinical Trial Controlled by Placebo with a Fos Enriched Cookie on Saciety and Cardiovascular Risk Factors in Obese Patients. Nutr. Hosp. 2013, 28(1), 78–85. DOI: 10.3305/nh.2013.28.1.6255.
   PubMed Web of Science ®Google Scholar
• Kareem, K. Y.; Hooi Ling, F.; Teck Chwen, L.; May Foong, O.; Anjas Asmara, S. Inhibitory Activity of Postbiotic Produced by Strains of Lactobacillus Plantarum Using Reconstituted Media Supplemented with Inulin. Gut Pathog. 2014, 6, 23. DOI: 10.1186/1757-4749-6-23.
   PubMed Web of Science ®Google Scholar
• Vieira, A. T.; Fukumori, C.; Ferreira, C. M. New Insights into Therapeutic Strategies for Gut Microbiota Modulation in Inflammatory Diseases. Clin. Transl. Immunol. 2016, 5(6), e87. DOI: 10.1038/cti.2016.38.
   PubMedGoogle Scholar
• Cicenia, A.; Scirocco, A.; Carabotti, M.; Pallotta, L.; Marignani, M.; Severi, C. Postbiotic Activities of Lactobacilli-Derived Factors. J. Clin. Gastroenterol. 2014, 48(Suppl 1), S18–22. DOI: 10.1097/MCG.0000000000000231.
   PubMedGoogle Scholar
• Haileselassie, Y.; Navis, M.; Vu, N.; Qazi, K. R.; Rethi, B.; Sverremark-Ekström, E. Postbiotic Modulation of Retinoic Acid Imprinted Mucosal-like Dendritic Cells by Probiotic Lactobacillus Reuteri 17938 in Vitro. Front. Immunol. 2016, 7, 96. DOI: 10.3389/fimmu.2016.00096.
   PubMed Web of Science ®Google Scholar
• Kareem, K. Y.; Loh, T. C.; Foo, H. L.; Akit, H.; Samsudin, A. A. Effects of Dietary Postbiotic and Inulin on Growth Performance, IGF1 and GHR MRNA Expression, Faecal Microbiota and Volatile Fatty Acids in Broilers. BMC Vet. Res. 2016, 12(1), 163. DOI: 10.1186/s12917-016-0790-9.
   PubMed Web of Science ®Google Scholar
• Kareem, K. Y.; Loh, T. C.; Foo, H. L.; Asmara, S. A.; Akit, H. Influence of Postbiotic RG14 and Inulin Combination on Cecal Microbiota, Organic Acid Concentration, and Cytokine Expression in Broiler Chickens. Poult. Sci. 2017, 96(4), 966–975. DOI: 10.3382/ps/pew362.
   PubMed Web of Science ®Google Scholar
• Tsilingiri, K.; Barbosa, T.; Penna, G.; Caprioli, F.; Sonzogni, A.; Viale, G.; Rescigno, M. Probiotic and Postbiotic Activity in Health and Disease: Comparison on a Novel Polarised Ex-Vivo Organ Culture Model. Gut. 2012, 61(7), 1007–1015. DOI: 10.1136/gutjnl-2011-300971.
   PubMed Web of Science ®Google Scholar